Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 2/20 | 0.60 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.60 |
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.51 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.51 |
| ▸ | GRM5 | P41594 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | FAAH | O00519 | 2/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3975841 | 0.86 | CHRNB2 (0.66) | CHRNB2CHRNA4TSHRLMNAALDH1A1 | |
| SCHEMBL3442965 | 0.86 | CHRNB2 (0.66) | CHRNB2CHRNA4TSHRLMNAALDH1A1 | |
| SCHEMBL15498199 | 0.85 | CHRNB2 (0.73) | CHRNB2CHRNA4TSHRLMNAALDH1A1 | |
| SCHEMBL16178929 | 0.85 | CHRNB2 (0.64) | CHRNB2CHRNA4TSHRLMNAALDH1A1 | |
| SCHEMBL28505899 | 0.85 | CHRNB2 (0.64) | CHRNB2CHRNA4TSHRLMNAALDH1A1 | |
| Hydrochloric Acid SCHEMBL10551173 | 0.84 | CHRNB2 (0.62) | CHRNB2CHRNA4TSHRLMNAALDH1A1 | |
| Hydrochloric Acid SCHEMBL10551164 | 0.84 | CHRNB2 (0.62) | CHRNB2CHRNA4TSHRLMNAALDH1A1 | |
| Hydrochloric Acid SCHEMBL10551171 | 0.84 | CHRNB2 (0.62) | CHRNB2CHRNA4TSHRLMNAALDH1A1 | |
| SCHEMBL2483461 | 0.82 | CHRNB2 (0.60) | CHRNB2CHRNA4TSHRLMNAALDH1A1 | |
| SCHEMBL10041787 | 0.82 | CHRNB2 (0.60) | CHRNB2CHRNA4TSHRLMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102617358-A | Preparation method of arylamine | LIANYUNGANG JINDUN AGROCHEMICAL CO LTD | 2012-08-01 | — | — | CN | claimed |
| CN-104011010-B | Bisaniline compounds and its manufacture method | 组合化学工业株式会社 | 2017-11-28 | — | — | CN | disclosed |
| CN-104011010-A | Diphenylamine compound and method for producing same | IHARA CHEMICAL IND CO | 2014-08-27 | — | — | CN | disclosed |
| CN-102617358-A | Preparation method of arylamine | LIANYUNGANG JINDUN AGROCHEMICAL CO LTD | 2012-08-01 | — | — | CN | disclosed |
| EP-2020849-A2 | PREPARATION AND UTILITY OF SUBSTITUTED CARBOXYLIC ACID COMPOUNDS | Auspex Pharmaceuticals Inc. (US) | 2009-02-11 | — | — | EP | disclosed |
| WO-2007140189-A2 | PREPARATION AND UTILITY OF SUBSTITUTED CARBOXYLIC ACID COMPOUNDS | AUSPEX PHARMACEUTICALS, INC. (US) | 2007-12-06 | — | — | WO | disclosed |
| EP-1581503-A4 | OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION | MERCK & CO INC (US) | 2007-07-25 | — | — | EP | disclosed |
| EP-1412343-B1 | COMPOUNDS, WHICH ARE POTENT INHIBITORS OF NA+/CA2+ EXCHANGE MECHANISM AND ARE USEFUL IN THE TREATMENT OF ARRHYTHMIAS | ORION CORP (FI) | 2006-08-30 | — | — | EP | disclosed |
| EP-1581503-A2 | OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION | Merck & Co., Inc. (US) | 2005-10-05 | — | — | EP | disclosed |
| WO-2004043354-A2 | OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION | MERCK & CO., INC. (US) | 2004-05-27 | — | — | WO | disclosed |